| Literature DB >> 20869467 |
Nizar Souayah1, P A Michas-Martin, Abu Nasar, Nataliya Krivitskaya, Hussam A Yacoub, Hafiz Khan, Adnan I Qureshi.
Abstract
Using data from Vaccine Adverse Event Reporting System, we identified 69 reports of Guillain-Barré Syndrome (GBS) after Gardasil vaccination that occurred in the United States between 2006 and 2009. The onset of symptoms was within 6 weeks after vaccination in 70% of the patients in whom the date of vaccination was known. The estimated weekly reporting rate of post-Gardasil GBS within the first 6 weeks (6.6 per 10,000,000) was higher than that of the general population, and higher than post-Menactra and post-influenza vaccinations. Further prospective active surveillance for accurate ascertainment and identification of high-risk groups of GBS after Gardasil vaccination is warranted. Copyright ÂEntities:
Mesh:
Substances:
Year: 2010 PMID: 20869467 DOI: 10.1016/j.vaccine.2010.09.020
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641